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Abstract
Background: Liposarcomas are among the most common sarcomas of adult life. Pleomorphic
liposarcoma, characterized by pleomorphic lipoblasts, is the rarest subtype. To our knowledge only
three cases of pleomorphic liposarcoma of the foot or ankle have been reported so far.
Case presentation: A 71-year-old female presented with a large growing mass on the dorsum of
her right foot. Computed tomography showed invasive tumorous mass. Excision biopsy revealed
the mass to be a pleomorphic liposarcoma, and below the knee amputation was performed.
Conclusion: Although the incidence of pleomorphic liposarcoma in the foot is very low, it is
essential to perform thorough histological analysis of all soft tissue masses, regardless of their
benign appearance, because only prompt radical surgery can result in a good prognosis for the
patient.
Background
Liposarcomas are malignant tumors and among the most
common soft tissue sarcomas of adult life [1]. They can be
devided according to clinicopathologic and cytogenetic
characteristics into three distinct subtypes: well-differenti-
ated, myxoid/round cell and pleomorphic liposarcoma
[1,2]. Pleomorphic liposarcomas are the rarest, and are
characterized by the presence of pleomorphic lipoblasts.
According to recent studies [3-5] pleomorphic liposarco-
mas occur most often in lower and upper limbs, and only
three have been found in foot and ankle, one of them
occurring in a burn scar [6].
We present a case of a pleomorphic liposarcoma of the
foot, stressing necessity of a proper histological analysis,
followed by radical surgery leading supposedly to a better
prognosis for the patient.
Case presentation
A 71-year-old female of normal weight presented with a
large mass on the dorsum of her right foot which has been
gradually increasing in size over 4 months prior to admis-
sion to the hospital. Two years before she had a soft tissue
injury at the same location, but without any complication
and sequels. Otherwise she was without serious illness.
Her family history revealed no lipomatous disorders. On
physical examination a firm, palpable tumor mass, 6–7
cm in diameter, poorly-defined from surrounding tissue
and attached to underlying structures and skin, was
detected. The mass was painless, unless examined by deep
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palpation. Skin above it was of normal color and struc-
ture. Laboratory findings, including blood count, were
completely normal. On plain x-rays only an ill defined
mass on the dorsum of the foot, with no clear correlation
to the bone, was observed. Computed tomography
revealed invasive tumorous mass. Scintigraphy with Tc99
was positive. Magnetic resonance imaging showed expan-
sive infiltrative process of the dorsum of the foot with
penetration between metatarsal bones to the plantar side,
and partial destruction of the fourth metatarsal bone. His-
tologically, in biopsy sample, areas with lipogenic charac-
teristics were surrounded by nonlipogenic areas (Figure
1A). In lipogenic areas lipoblasts of different size and
shape with variably expressed pleomorphism and number
of nuclei were found (Figure 1B,C). The number of lipob-
lasts also varied considerably from field to field as was the
intensity of mixoid change so that some areas had a myxo-
fibrosarcoma-like appearance, a pattern dominating the
first biopsy (Figure 1). In nonlipogenic areas sheets of ple-
omorphic spindle cells with multinucleated giant cells
(complying to the pattern of so called malignant fibrous
histiocytoma, MFH) were interspersed with more pleo-
morphic parts or dense collagen (Figure 1D,E). Occasion-
ally some cells showed rhabdoid or epitheloid features
(Figure 1F). No significant necrosis was present. A panel
of antibodies was studied immunohistochemically:
vimentin, S-100, desmin, CD34, CD68, cytokeratin, epi-
thelial membrane antigen (EMA), myoglobin, myogenin
and smooth muscle actin (SMA) (all antibodies from
DAKO; Copenhagen, Denmark). In tumor cells S-100 was
occasionally positive with better expression in lipogenic
than in non-lipogenic areas. Positivity for CD68 and myo-
genin were observed rarely. CD 34 and SMA were positive
only in vessel walls, and negative in tumor, while other
antibodies yielded no specific staining. Proliferation rate
measured with Ki-67 was 40% measured in hot spot areas.
After histological diagnosis below the knee amputation
was indicated. No further therapy was indicated, and
patient is still alive, 6.5 years after the diagnosis was made.
Discussion
Pleomorphic liposarcoma is a rare neoplasm, and until
know there have been only 3 reported cases of pleomor-
phic liposarcoma in the foot and ankle. It is known that
this neoplasm is usually aggressive, occurring in adult-
hood, and usually in the limbs. Pleomorphic liposarcoma
can occur in mediastinum, liver, orbit, paratesticular
region, and also as a purely dermal tumor [3,4,7-11] and
are presented as single case studies or in review articles. It
Histological presentation Figure 1
Histological presentation. Histological presentation of lipogenic and nonlipogenic areas (A), with pleomorphic lipoblasts (B, 
C) in lipogenic areas. In nonlipogenic areas pleomorphic spindle cells were interspersed with dense collagen (D, E), while some 
showed rhabdoid or epitheloid features (F). (hemalaun-eosyn staining; A, B, D-objective ×2; C, F-objective ×25; E-objective 
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usually presents as a painless, deep-seated tumorous mass
[3]. It can easily be misdiagnosed, because of the great
variety of histological presentations. Histological hall-
mark of pleomorphic liposarcoma are pleomorphic
lipoblast, which can form less than 10% of the tumor.
Immunohistochemistry has a limited value in diagnostic
procedures. According to Gebhard et al. S-100 protein
immunoreactivity can be observed in up to 48% of lipo-
genic areas, while SMA was positive in 49% of nonlipo-
genic areas of pleomorphic liposarcoma [3]. They
differentiate four morphological subtypes of pleomorphic
liposarcoma, based on the appearance of nonlipogenic
parts of the tumor: malignant fibrous histiocytoma-like,
epithelioid, round cell and spindle cell liposarcoma-like.
This classification is in contrast with the view of Enzinger
and Weis recognizing only 2 subtypes (MFH-like and with
round and pleomorphic cells) [2]. Some dedifferentiated
and pleomorphic liposarcomas have been reported to be
associated with leukocytosis. This feature, usually
expressed in MFH, led to the concept of possible common
lineage for MFH, dedifferentiated and pleomorphic
liposarcoma [12]. Differential diagnosis includes dediffer-
entiated liposarcoma, myxofibrosarcoma, leiomyosar-
coma, rhabdomyosarcoma, carcinoma, and melanoma,
which may be difficult to distinguish especially in small
biopsies. This is especially true for dedifferentiated liposa-
rcoma where quality of sampling represents the key
parameter in avoiding underdiagnosis. Only adequate
sampling will identify both well/and poorly differentiated
areas of a given tumor. The distinction from nonlipogenic
tumors is based on demonstration of multivacuolated
lipoblasts and occasional positivity for S-100 protein in
the spindle or poorly differentiated areas. The most com-
plicated task is the differential diagnosis of tumors with
highly pleomorphic (MFH-like) features. The differential
diagnosis in the groups with round or pleomorphic cells,
including epitheloid appearance, largely depends on spe-
cific immunohistochemistry for the given tumors. In dis-
tinction from poorly differentiated epithelial neoplasms
the positivity of occasional cells for epithelial markers
should be kept in mind [13]. In all cases inadequate sam-
pling represents one of the basic problems.
Molecular studies so far yielded little useful results: in one
third of the patients MDM2 amplification was detected,
and TP53 alterations were present in four out of nine
patients (all without MDM2 amplification) [14].
We presented a case of a 71-year old female, with tumor-
ous mass on the dorsum of her right foot, which, accord-
ing to pathohistological analysis, turned out to be a
pleomorphic liposarcoma, showing areas of different his-
tology. Our case demonstrates the importance of patho-
histological analysis of all soft tissue tumorous masses in
the foot/ankle region, which may look like common
benign soft tissue lesions, but if not recognized can
become life-threatening.
Conclusion
It is important to bear in mind that the differential diag-
nosis of pleomorphic lyposarcoma is fairly broad and that
thorough sampling and searching for lipoblasts may be
rewarding in tumors firstly presenting histologically as
one of the mimics (e.g. MFH, myxofibrosarcoma or even
metastatic carcinoma or melanoma).
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